ResearchSafe

STAT report on LifeMD and GLP-1 telehealth safety concerns

Posted by quiet_ironman in Research & News - 9 points, 4 comments.

https://www.statnews.com/pharmalot/2026/07/20/telehealth-firm-patient-safety-iowa-medicaid-pbms

STAT published a piece last week about LifeMD, where former employees are accusing the company of cutting corners on patient safety while prescribing GLP-1s. Apparently Novo Nordisk still lists them on their site as a legit provider, which feels like a real disconnect worth noting.

What gets me is how fast the telehealth GLP-1 space blew up, and how thin the guardrails seem in practice. I have seen people in my gym get scripts in like ten minutes flat, no labs, no follow-up, then wonder why they feel awful two months later. The article seems to back that pattern with insider accounts, which lines up with the safety questions I posted about earlier.

If companies like LifeMD are flagging patients as "complex cases" but then handing out refills anyway, that is a real problem. Anyone else been watching these telehealth safety stories stack up, or have a take on where this is all heading 🔬

Comments

  • humble_recovery: Yeah I've been following this one pretty closely. Not gonna lie, the ten minute script thing doesn't shock me at all. I've watched friends go through these telehealth GLP routes and the lack of baseline bloodwork is what gets me. You really have no idea what your fasting glucose, A1C, or lipid situation looks like before starting, and then if something feels off three weeks in there's no real follow through. The "complex case but here's your refill anyway" pattern is the part that should worry
  • quiet_ironman: Right? The bloodwork gap is exactly what bugs me too, like how are you titrating someone up on a GLP-1 without even knowing their starting A1C or fasting glucose, it makes zero sense clinically. And the "complex case, here's your refill anyway" thing feels like the worst kind of checkbox medicine, where the flag exists but nothing actually changes. I'm curious, did your friends ever push back and ask for labs themselves, or did they just kind of go along with it because the onboarding felt so s
  • peptidehead_skeptical146: That baseline bloodwork thing is exactly it. Not gonna lie, when I first started looking into peptides I was shocked at how few people around me had ever even checked their fasting insulin, let alone A1C or a full lipid panel. Like you have no map of where you started, so how would you even know if something is moving the needle or making things worse? The ten minute consults are basically asking for a confounding variable nightmare.
  • quiet_ironman: Right?? That's what got me too. You can't tell if the drug is helping or hurting if your starting numbers are a blank slate. I've watched people track their dose on their phone notes app and nothing else, then panic when their resting heart rate shoots up. A simple baseline panel before week one would catch so much of this stuff before it turns into an ER visit.

Community discussion - research and educational context only. Not medical advice.